DGX News & Events

Quest Diagnostics has elected Timothy Wentworth to serve as a director. Including Wentworth, the company's board has eleven members. Wentworth was most recently CEO of Walgreens Boots Alliance. Prior to that, he was founding CEO of Evernorth Health Services, the health services organization of The Cigna Group. In addition, Wentworth was president and CEO of Express Scripts, one of the largest pharmacy benefit managers in the United States. Wentworth's experience also includes senior leadership roles with consumer brands, including COO at Mary Kay, and director roles in human resources at PepsiCo. Wentworth serves on the boards of directors of Walgreens Holding and Dfinitiv, and previously served on the boards of Walgreens Boots Alliance, Accredo Health Group, Express Scripts, and Forge Health.

Quest Diagnostics announced that Benjamin Beauvalot has joined the company as SVP, Chief Strategy and M&A Officer. Prior to joining Quest, Beauvalot held leadership positions in strategy and M&A with Danaher Corporation, including VP and head of business development and strategy for Danaher's biotechnology and genomics business areas. Beauvalot also served as vice president of strategy and corporate development and vice president of global business operations for Patheon. He was also vice president of strategy for Banner Life Sciences. Beauvalot succeeds Dermot Shorten, who is retiring in Q2 after having held the role since 2008.